Trial Profile
Treatment of AKs With Daylight-PDT: Comparing Two Photosensitizers (BF-200 ALA and MAL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2023
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary) ; Methyl aminolevulinate
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 04 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Mar 2014 New trial record